Across the Middle East and North Africa (MENA), the age-standardized rates (ASRs) of hepatitis B virus (HBV) burden may be declining while the absolute burden rises among middle-aged and older adults. In this study, we aimed to characterize changes in rates, counts, and age distribution across 21 MENA countries, with Oman as a case study.
We analyzed Global Burden of Disease 2023 estimates for 1990–2023. Disability-adjusted life-years (DALYs) were used to measure the overall HBV-related burden, and acute hepatitis B incidence was examined as a secondary outcome. We compared population-weighted means of country ASRs with aggregated counts, assessed rate-count divergence, and summarized DALYs across four fixed age bands.
The population-weighted mean DALY ASR declined 53.0%, from 624.5 to 293.6 per 100,000 (estimated annual percentage change −2.28%; 95% confidence interval −2.34 to −2.23), while absolute DALYs increased 19.3%, from 1.18 to 1.41 million. Mean burden age increased in 20 countries, by up to 12.4 years, and the 0–34-year DALY share declined in 19 countries. In Oman, DALYs and acute-incidence ASRs declined 38.6% and 49.2%, while DALYs at ages 35–54 increased 2.55-fold and represented 43.3% of national HBV DALYs in 2023.
HBV burden in MENA is shifting toward middle-aged and older adults while absolute DALYs rise despite declining ASRs. Service planning should consider counts and age distribution alongside rates, with sustained vaccination complemented by adult diagnosis, treatment, cirrhosis care, and hepatocellular carcinoma surveillance.
Full article